_id
691b0fbf3c536f8df2318a53
Ticker
ALNFL.PA
Name
NFL Biosciences SAS
Exchange
PA
Address
199 Rue HElEne Boucher, Castelnau-le-Lez, France, 34170
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.nflbiosciences.com
Description
NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company's pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France.
Last Close
1.18
Volume
18803
Current Price
1.208
Change
-1.8644067796610189
Last Updated
2025-12-30T12:40:19.434Z
Image
https://logo.clearbit.com/www.nflbiosciences.com
Ipo Date
-
Market Cap
14446356
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
40917
Gross Profit
-40917
Operating Expenses
2080242
Operating Income
-2121162
Interest Expense
9976
Pretax Income
-2123336
Net Income
-1803721
Eps
-0.1423363758362569
Dividends Per Share
-
Shares Outstanding
12672242
Income Tax Expense
-319615
EBITDA
-2072440
Operating Margin
-
Total Other Income Expense Net
-2174
Cash
2928269
Short Term Investments
200000
Receivables
988204
Inventories
-
Total Current Assets
4141791
Property Plant Equipment
111165
Total Assets
4423152
Payables
-
Short Term Debt
30330
Long Term Debt
-
Total Liabilities
2602762
Equity
1820389
Bs_currency_symbol
-
Depreciation
40917
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
8.409229201011433
ROE
-99.08437152718457
ROA
-40.779086949758906
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
24
Deep Value Investing Score
2
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
2.3
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
1.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
40917
Quarters > 0 > income Statement > gross Profit
-40917
Quarters > 0 > income Statement > operating Expenses
2080242
Quarters > 0 > income Statement > operating Income
-2121162
Quarters > 0 > income Statement > interest Expense
9976
Quarters > 0 > income Statement > pretax Income
-2123336
Quarters > 0 > income Statement > net Income
-1803721
Quarters > 0 > income Statement > eps
-0.1423363758362569
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12672242
Quarters > 0 > income Statement > income Tax Expense
-319615
Quarters > 0 > income Statement > EBITDA
-2072440
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2174
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2928269
Quarters > 0 > balance Sheet > short Term Investments
200000
Quarters > 0 > balance Sheet > receivables
988204
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
4141791
Quarters > 0 > balance Sheet > property Plant Equipment
111165
Quarters > 0 > balance Sheet > total Assets
4423152
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
30330
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2602762
Quarters > 0 > balance Sheet > equity
1820389
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
40917
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.1423363758362569
Quarters > 0 > ratios > PB
8.409229201011433
Quarters > 0 > ratios > ROE
-99.08437152718457
Quarters > 0 > ratios > ROA
-40.779086949758906
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
41230
Quarters > 1 > income Statement > gross Profit
-41230
Quarters > 1 > income Statement > operating Expenses
1852794
Quarters > 1 > income Statement > operating Income
-1894026
Quarters > 1 > income Statement > interest Expense
162
Quarters > 1 > income Statement > pretax Income
-1862963
Quarters > 1 > income Statement > net Income
-1349330
Quarters > 1 > income Statement > eps
-0.13726006598061558
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9830463
Quarters > 1 > income Statement > income Tax Expense
-513633
Quarters > 1 > income Statement > EBITDA
-1821568
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
31063
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1913523
Quarters > 1 > balance Sheet > short Term Investments
200000
Quarters > 1 > balance Sheet > receivables
1058350
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
3339663
Quarters > 1 > balance Sheet > property Plant Equipment
124901
Quarters > 1 > balance Sheet > total Assets
3609849
Quarters > 1 > balance Sheet > payables
1147603
Quarters > 1 > balance Sheet > short Term Debt
40975
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2633419
Quarters > 1 > balance Sheet > equity
976430
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
41230
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.13726006598061558
Quarters > 1 > ratios > PB
12.161854207674896
Quarters > 1 > ratios > ROE
-138.1901416384175
Quarters > 1 > ratios > ROA
-37.379125830471025
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
25913
Quarters > 2 > income Statement > gross Profit
-25913
Quarters > 2 > income Statement > operating Expenses
870150
Quarters > 2 > income Statement > operating Income
-896065
Quarters > 2 > income Statement > interest Expense
142
Quarters > 2 > income Statement > pretax Income
-853286
Quarters > 2 > income Statement > net Income
-731509
Quarters > 2 > income Statement > eps
-0.07537085041692498
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9705463
Quarters > 2 > income Statement > income Tax Expense
-121777
Quarters > 2 > income Statement > EBITDA
-827230
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
42779
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3546153
Quarters > 2 > balance Sheet > short Term Investments
200000
Quarters > 2 > balance Sheet > receivables
929448
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4722118
Quarters > 2 > balance Sheet > property Plant Equipment
123245
Quarters > 2 > balance Sheet > total Assets
5009176
Quarters > 2 > balance Sheet > payables
1365076
Quarters > 2 > balance Sheet > short Term Debt
23026
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2720915
Quarters > 2 > balance Sheet > equity
2288260
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
25913
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
-
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.07537085041692498
Quarters > 2 > ratios > PB
5.1236307517502375
Quarters > 2 > ratios > ROE
-31.967914485242062
Quarters > 2 > ratios > ROA
-14.603379877249273
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
27
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
27307
Quarters > 3 > income Statement > gross Profit
-27307
Quarters > 3 > income Statement > operating Expenses
1925953
Quarters > 3 > income Statement > operating Income
-1953260
Quarters > 3 > income Statement > interest Expense
6277
Quarters > 3 > income Statement > pretax Income
-1800870
Quarters > 3 > income Statement > net Income
-1634826
Quarters > 3 > income Statement > eps
-0.2016618457982459
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8106769
Quarters > 3 > income Statement > income Tax Expense
-166044
Quarters > 3 > income Statement > EBITDA
-1767290
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
152390
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2338044
Quarters > 3 > balance Sheet > short Term Investments
191445
Quarters > 3 > balance Sheet > receivables
1108656
Quarters > 3 > balance Sheet > inventories
-1108656
Quarters > 3 > balance Sheet > total Current Assets
3820526
Quarters > 3 > balance Sheet > property Plant Equipment
9060
Quarters > 3 > balance Sheet > total Assets
3970628
Quarters > 3 > balance Sheet > payables
2163892
Quarters > 3 > balance Sheet > short Term Debt
22971
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3620683
Quarters > 3 > balance Sheet > equity
349945
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-
Quarters > 3 > cash Flow > depreciation
27307
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
-
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.2016618457982459
Quarters > 3 > ratios > PB
27.984331686407863
Quarters > 3 > ratios > ROE
-467.166554744317
Quarters > 3 > ratios > ROA
-41.17298321575328
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
46
Annuals > 0 > income Statement > cost Of Revenue
1546316
Annuals > 0 > income Statement > gross Profit
-67143
Annuals > 0 > income Statement > operating Expenses
2722944
Annuals > 0 > income Statement > operating Income
-2790091
Annuals > 0 > income Statement > interest Expense
304
Annuals > 0 > income Statement > pretax Income
-2716249
Annuals > 0 > income Statement > net Income
-2080839
Annuals > 0 > income Statement > eps
-0.21167253261621552
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
9830463
Annuals > 0 > income Statement > income Tax Expense
-635410
Annuals > 0 > income Statement > EBITDA
-2648798
Annuals > 0 > income Statement > operating Margin
-6065415.217391304
Annuals > 0 > income Statement > total Other Income Expense Net
73842
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
1913523
Annuals > 0 > balance Sheet > short Term Investments
200000
Annuals > 0 > balance Sheet > receivables
1058350
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3339663
Annuals > 0 > balance Sheet > property Plant Equipment
124901
Annuals > 0 > balance Sheet > total Assets
3609849
Annuals > 0 > balance Sheet > payables
1147603
Annuals > 0 > balance Sheet > short Term Debt
40975
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2633419
Annuals > 0 > balance Sheet > equity
976430
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-2080839
Annuals > 0 > cash Flow > depreciation
67143
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.21167253261621552
Annuals > 0 > ratios > PB
11.316162358796843
Annuals > 0 > ratios > ROE
-213.10682793441416
Annuals > 0 > ratios > ROA
-57.64338065110203
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
20
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
200011
Annuals > 1 > income Statement > cost Of Revenue
56064
Annuals > 1 > income Statement > gross Profit
-56064
Annuals > 1 > income Statement > operating Expenses
4374353
Annuals > 1 > income Statement > operating Income
-4430420
Annuals > 1 > income Statement > interest Expense
6506
Annuals > 1 > income Statement > pretax Income
-4111868
Annuals > 1 > income Statement > net Income
-3745476
Annuals > 1 > income Statement > eps
-0.46201834540986675
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8106769
Annuals > 1 > income Statement > income Tax Expense
-366393
Annuals > 1 > income Statement > EBITDA
-4049302
Annuals > 1 > income Statement > operating Margin
-2215.088170150642
Annuals > 1 > income Statement > total Other Income Expense Net
318552
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
2338044
Annuals > 1 > balance Sheet > short Term Investments
191445
Annuals > 1 > balance Sheet > receivables
1108656
Annuals > 1 > balance Sheet > inventories
-1108656
Annuals > 1 > balance Sheet > total Current Assets
3820526
Annuals > 1 > balance Sheet > property Plant Equipment
9060
Annuals > 1 > balance Sheet > total Assets
3970628
Annuals > 1 > balance Sheet > payables
2163892
Annuals > 1 > balance Sheet > short Term Debt
22971
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3620683
Annuals > 1 > balance Sheet > equity
349945
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-3745476
Annuals > 1 > cash Flow > depreciation
56064
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.46201834540986675
Annuals > 1 > ratios > PB
26.038401337353015
Annuals > 1 > ratios > ROE
-1070.3041906585322
Annuals > 1 > ratios > ROA
-94.32956197357194
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
2235726
Annuals > 2 > income Statement > gross Profit
-2235726
Annuals > 2 > income Statement > operating Expenses
668956
Annuals > 2 > income Statement > operating Income
-3013533
Annuals > 2 > income Statement > interest Expense
493
Annuals > 2 > income Statement > pretax Income
-2861314
Annuals > 2 > income Statement > net Income
-2443485
Annuals > 2 > income Statement > eps
-0.46679390946263066
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5234612
Annuals > 2 > income Statement > income Tax Expense
-417829
Annuals > 2 > income Statement > EBITDA
-2808379
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
152220
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
1053581
Annuals > 2 > balance Sheet > short Term Investments
160855
Annuals > 2 > balance Sheet > receivables
742287
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2257611
Annuals > 2 > balance Sheet > property Plant Equipment
2089
Annuals > 2 > balance Sheet > total Assets
2395484
Annuals > 2 > balance Sheet > payables
1187048
Annuals > 2 > balance Sheet > short Term Debt
83249
Annuals > 2 > balance Sheet > long Term Debt
83256
Annuals > 2 > balance Sheet > total Liabilities
1551487
Annuals > 2 > balance Sheet > equity
843997
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-2443484
Annuals > 2 > cash Flow > depreciation
52444
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
104888
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-1985989
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.46679390946263066
Annuals > 2 > ratios > PB
6.971237916722453
Annuals > 2 > ratios > ROE
-289.51346983460843
Annuals > 2 > ratios > ROA
-102.00381217323931
Annuals > 2 > ratios > FCF
104888
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
36
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
39
Annuals > 3 > income Statement > cost Of Revenue
530733
Annuals > 3 > income Statement > gross Profit
-530733
Annuals > 3 > income Statement > operating Expenses
371173
Annuals > 3 > income Statement > operating Income
-901867
Annuals > 3 > income Statement > interest Expense
538
Annuals > 3 > income Statement > pretax Income
-1119510
Annuals > 3 > income Statement > net Income
-978244
Annuals > 3 > income Statement > eps
-0.1868799444925431
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5234612
Annuals > 3 > income Statement > income Tax Expense
-141266
Annuals > 3 > income Statement > EBITDA
-1075469
Annuals > 3 > income Statement > operating Margin
-2312479.487179487
Annuals > 3 > income Statement > total Other Income Expense Net
-217642
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
3039570
Annuals > 3 > balance Sheet > short Term Investments
165286
Annuals > 3 > balance Sheet > receivables
219942
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
3559179
Annuals > 3 > balance Sheet > property Plant Equipment
1987
Annuals > 3 > balance Sheet > total Assets
3685207
Annuals > 3 > balance Sheet > payables
65583
Annuals > 3 > balance Sheet > short Term Debt
85007
Annuals > 3 > balance Sheet > long Term Debt
7
Annuals > 3 > balance Sheet > total Liabilities
397726
Annuals > 3 > balance Sheet > equity
3287481
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-978243
Annuals > 3 > cash Flow > depreciation
43501
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
87000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
2729369
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.1868799444925431
Annuals > 3 > ratios > PB
1.7897301575279068
Annuals > 3 > ratios > ROE
-29.756643460448895
Annuals > 3 > ratios > ROA
-26.54515743620372
Annuals > 3 > ratios > FCF
87000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
2230.769230769231
Annuals > 3 > health Score
54
Valuation > metrics > PE
-0.1423363758362569
Valuation > metrics > PB
8.409229201011433
Valuation > final Score
20
Valuation > verdict
180.3% Overvalued
Profitability > metrics > ROE
-99.08437152718457
Profitability > metrics > ROA
-43.549300290623066
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.42978341442406
Risk > metrics > Interest Coverage
-212.62650360866078
Risk > final Score
-821
Risk > verdict
High
Liquidity > metrics > Current Ratio
136.55756676557863
Liquidity > metrics > Quick Ratio
136.55756676557863
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
28.763692482497625
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-46748
Prev Risks > 1
-25211
Prev Risks > 2
-1239
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
94
Updated At
2026-01-20T23:09:00.615Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-16
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2023-03-31
Earnings History > 1 > report Date
2023-06-20
Earnings History > 1 > date
2023-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
EUR
Earnings History > 1 > eps Actual
-0.26
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.26
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-10-26
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.2
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.2
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-03-31
Earnings History > 3 > report Date
2022-04-29
Earnings History > 3 > date
2022-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.16
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.16
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-09-30
Earnings History > 4 > report Date
2021-10-04
Earnings History > 4 > date
2021-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.04
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.04
Earnings History > 4 > surprise Percent
-
NFL Biosciences SA, a biotechnology company, engages in the development of botanical drugs in France. The company's pipeline includes NFL-101, a drug candidate for smoking cessation, currently under Phase 2b clinical trials; and NFL-301, a drug candidate for reducing alcohol consumption which is in preclinical stage. It has scientific collaboration with McLean Hospital to deepen the understanding of the mechanism of action of NFL-101, its proprietary botanical drug candidate for smoking cessation. NFL Biosciences SA was incorporated in 2006 and is headquartered in Castelnau-le-Lez, France.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AALNFL.PA +15.60% intraday 21 Jan 2026 (NFL Biosciences, EURONEXT): heavy volume may signal catalyst Meyka
Read more →(Last Updated 2025-06-30)
Rating:
HOLD
$
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of NFL Biosciences SAS
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.